Banafshe, H.R. and Pashapour, S. and Dehkohneh, S.G. and Ghaderi, A. (2018) Vitamin D in neurological and neurodegenerative patients: Current knowledge and future perspectives. International Journal of Pharmaceutical Research, 10 (4). pp. 781-790.
|
Text
scopusresults(11).pdf Download (60kB) | Preview |
Abstract
Effective pharmacological treatments for neurological and neurodegenerative patients have not yet been identified. Previous studies show that vitamin D may be involved in neurodevelopment adult brain. Reduced status of vitamin D have been reported in various neurological and neurodegenerative disorders. Insufficient levels of vitamin D in neurological and neurodegenerative have been confirmed. The neuroprotective effect of vitamin D is associated with its effects on neurotrophin synthesis and prevention of oxidative or inflammation damage to nervous tissue. We here review the role of vitamin D in the pathogenesis disease, such as seizure, Pain, depression and anxiety, sleep, sexual dysfunction, addiction, alzheimer's, parkinson's. Adequate administrate of vitamin D in the lifetime seems to be crucial in terms of prevention of these diseases. The aim of this review is to assess the current knowledge related to the role of vitamin D supplementation on the pathogenesis and disease course of neurological and neurodegenerative. © 2018, Advanced Scientific Research. All rights reserved.
| Item Type: | Article |
|---|---|
| Additional Information: | cited By 0 |
| Subjects: | Pharmacology, Toxicology and Pharmaceutics |
| Divisions: | Faculty of Medicine > Basic Sciences > Department of Pharmacology |
| Depositing User: | ART . editor |
| Date Deposited: | 20 Apr 2019 11:44 |
| Last Modified: | 20 Apr 2019 11:44 |
| URI: | http://eprints.kaums.ac.ir/id/eprint/3835 |
Actions (login required)
 |
View Item |
